| Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma A Schuessler, C Smith, L Beagley, GM Boyle, S Rehan, K Matthews, ... Cancer research 74 (13), 3466-3476, 2014 | 203 | 2014 |
| Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases V Dasari, C Smith, R Khanna Expert review of vaccines 12 (6), 661-676, 2013 | 51 | 2013 |
| Autophagy and proteasome interconnect to coordinate cross‐presentation through MHC class I pathway in B cells V Dasari, S Rehan, SK Tey, MJ Smyth, C Smith, R Khanna Immunology and Cell Biology 94 (10), 964-974, 2016 | 40 | 2016 |
| Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of … V Dasari, C Smith, J Zhong, G Scott, W Rawlinson, R Khanna Journal of general virology 92 (5), 1021-1031, 2011 | 37 | 2011 |
| Prophylactic and therapeutic strategies for Epstein–Barr virus-associated diseases: emerging strategies for clinical development V Dasari, D Sinha, MA Neller, C Smith, R Khanna Expert review of vaccines 18 (5), 457-474, 2019 | 36 | 2019 |
| Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8+ T cells C Smith, D Elhassen, S Gras, KK Wynn, V Dasari, J Tellam, SK Tey, ... Blood, The Journal of the American Society of Hematology 120 (16), 3237-3245, 2012 | 35 | 2012 |
| Impaired Epstein-Barr virus-specific neutralizing antibody response during acute infectious mononucleosis is coincident with global B-cell dysfunction A Panikkar, C Smith, A Hislop, N Tellam, V Dasari, KA Hogquist, M Wykes, ... Journal of virology 89 (17), 9137-9141, 2015 | 31 | 2015 |
| Cytokine-mediated loss of blood dendritic cells during Epstein-Barr virus–associated acute infectious mononucleosis: Implication for immune dysregulation A Panikkar, C Smith, A Hislop, N Tellam, V Dasari, KA Hogquist, M Wykes, ... The Journal of infectious diseases 212 (12), 1957-1961, 2015 | 30 | 2015 |
| Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities V Dasari, KH Bhatt, C Smith, R Khanna Expert Review of Vaccines 16 (4), 377-390, 2017 | 26 | 2017 |
| Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients V Dasari, A Schuessler, C Smith, Y Wong, JJ Miles, MJ Smyth, ... Molecular Therapy Methods & Clinical Development 3, 2016 | 16 | 2016 |
| Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunity V Dasari, C Smith, A Schuessler, J Zhong, R Khanna Human vaccines & immunotherapeutics 10 (4), 1064-1077, 2014 | 13 | 2014 |
| Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice V Dasari, LK McNeil, K Beckett, M Solomon, G Ambalathingal, TL Thuy, ... Nature Communications 14 (1), 4371, 2023 | 12 | 2023 |
| A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice V Dasari, K Beckett, S Horsefield, G Ambalathingal, R Khanna PLoS Pathogens 18 (6), e1010403, 2022 | 5 | 2022 |
| Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients K Hardy, C Smith, WJ Tu, R McCuaig, A Panikkar, V Dasari, F Wu, SK Tey, ... Blood advances 2 (6), 656-668, 2018 | 5 | 2018 |
| Human cytomegalovirus polyepitope vaccine composition R Khana, V Dasari US Patent App. 17/921,945, 2023 | | 2023 |
| Multivirus-specific t cell immunotherapy R Khanna, V Dasari US Patent App. 17/886,270, 2023 | | 2023 |
| PROTEIN FOR IMPROVED HUMAN HERPESVIRUS IMMUNOTHERAPY D KHANNA, Rajiv and VIJAYENDRA JP Patent 7,110,302, 2022 | | 2022 |
| A Lymph Node Targeted Adjuvant and Engineered Subunit Vaccine Promotes Potent Immunity to Epstein-Barr Virus in HLA-expressing Mice V Dasari, L McNeil, K Beckett, M Solomon, G Ambalathingal, M Steinbuck, ... | | 2022 |
| Multivirus-specific t cell immunotherapy R Khanna, V Dasari US Patent App. 16/318,555, 2021 | | 2021 |
| MULTIVIRUS-SPECIFIC T-LYMPHOCYTES IMMUNOTHERAPY R Khanna, V Dasari | | 2020 |
